Covid Kappa Variant Symptoms, Vaccine Efficacy, Precautions, Severity

Covid Kappa Variant : Kappa variant is a variant of SARS-CoV-2, the virus that causes COVID-19. It’s one of the 3 sublineages of Pango lineage B.1.617. The SARS-CoV-2 Kappa variant is as well popular as lineage B.1.617.1 &  was 1st detected in India in December 2020. By the last of March 2021, the Kappa sub-variant accounted for more than half of the series being submitted from India. On 1 April 2021, it was deputed a Variant Under Investigation (VUI-21APR-01) by Public Health England.

In this writing we’re providing detail about Corona Kappa Variant Symptoms, Vaccine Efficacy, Precautions, Treatment, Cases Details.

Covid Kappa Variant

The Kappa variant is a double mutant with the same lineage as the Delta variant which is recognized as B.1.617.1. Interestingly the Delta variant, founded around the same times as Kappa, was announced a variant of interest on the same date of April 4. It was recategorized a variant of worry more than a month later on May 11.

It’s 1 of the 3 sublineages of Pango lineage B.1.617. 11 cases of Kappa variant of COVID-19 have ben disclosed in Rajasthan, stated State Health Minister Raghu Sharma on Tuesday. Addressing a press briefing last week, Dr VK Paul, Member-Health, NITI Aayog had said that the Kappa variant of COVID-19 is a “variant of interest” and it isn’t a new variant as cases have reported in the nation before. He further informed that Kappa variant is of much less intensity and was earlier reported in February & March.

Covid Kappa Variant


Covid Kappa Variant Details

Post Title Kappa Variant Covid Symptoms, Severity, Effective vaccines and Precautions
New Covid-19 Variant Name Kappa
Scientific name of Covid-19 Kappa variant B.1.617.1
Article Category Health
Official Site


What is the Kappa variant?

A per the WHO, the Kappa variant, which is the B.1.617.1 strain of SARS-CoV-2, is the only other COVID-19 variant that was 1st recognized in India. But, it’s not a new variant. In accordance with the World Health Organization, the Kappa variant was 1st point out in India in October 2020.

Related – Covaxin vs Covishield vs Sputnik V

The Delta & Kappa variants are actually siblings, the direct offshoot of a variant that earlier utilized to mention to as the double mutant, or B.1.617. Lastly, the major variants of coronavirus were mentioned to by the name of the nation where they were 1st identified to have emerged. So, they utilized to whoop by names including “UK variant”, “South Africa variant” & “Brazil variant”, while the double mutant B.1.617 utilized to call the “India variant”.

Covid Kappa Variant Symptoms

A Kappa variant infection has similar signs to other COVID-19 variants – flu, fever, headache, aches, prolonged cough, dry mouth, to loss of smell and taste. But, one epidemiologist from Griffith University Australia, Dicky Budiman confirmed recently identified to VOI that a number of people who were infected with a Kappa strain experience measles-like signs initially.

Read Also – COVID 19 Vaccine Certificate 2023

According to him, the first signs of Kappa variant infection rashes all over the body, high fever, cough, runny nose & red and watery eyes. The signs begin looking similar to other infections from other COVID-19 strains the next day, he recommended.

Covid19 Kappa Variant Severity

In India, the Delta variant overshadowed the Kappa variant which has meant that there have not enough studies & literature available around it. The Kappa variant was reported to be behind the outbreak that forced the Australian city of Melbourne into lockdown in May.

Read Also – Black Fungus Disease Infection

Kappa Variant Vaccine

It’s  believed that Kappa variant’s antibody neutralizing capabilities may slightly decrease the effectiveness for both vaccines & immunity generated from natural infections. Moreover, according to a study released in June, both the Pfizer-BioNTech & the AstraZeneca (branded Covishield in India) vaccines were found to remain broadly effective opposed to Delta also as Kappa variants. In accordance with the study by Oxford University researchers, issued in the journal Cell, “There is no proof of widespread escape recommending that the current generation of vaccines will give protection opposed to the B.1.617 lineage.”

Also Check – COVID Vaccine Registration Haryana

How to Safe from Kappa variants?

  1. Wear a double mask while leaving the house.
  2. Keep utilizing sanitizer when you’re out of the house.
  3.  Leave the house only if it’s compulsory.
  4. Don’t forget to comply social distancing outside the house.
  5. Wash hands thoroughly many times a day for about 20 seconds.
  6. Ensure to disinfect the goods brought from outside.
  7. Take a bath after coming from outside.
  8. Disinfect such surfaces of the house that are utilizing many times.
  9. Throw the disposable mask in the dustbin only after one utilize.

Related Other Posts – 

Covid Vaccine Registration

Cowin Vaccine Certificate Correction

H3N2 Influenza Virus Symptoms

Coronavirus Symptoms

Omicron Sub Variant BF.7 Symptoms

COVID19 Vaccination Certificate

Covid19 Vaccine Certificate Download

Frequently Asked Questions

How effective is the vaccine against Delta variant infection?

Vaccination status was including as a time-varying exposure. In the oldest age group, VE against infection after 2 doses was 90.7% (95% CI: 88.2; 92.7) for the Alpha variant, 82.3% (95% CI: 75.5; 87.2) for the Delta variant, and 39.9% (95% CI: 26.3; 50.9) for the Omicron variant 14 to 30 days since vaccination.

How effective is the vaccine for variants of concern?

First, full vaccination of COVID-19 vaccines was effective against Alpha, Beta, Gamma, Delta, and Omicron variants, with the VE of 88.0%, 73.0%, 63.0%, 77.8%, and 55.9%, respectively. Second, booster vaccination has higher VE against Delta and Omicron variants, with the VE of 95.5% and 80.8%, respectively.

How effective is the COVID vaccine for immunity?

For hybrid immunity, protection against hospital admission or severe disease was 97% at 12 months with primary series vaccination and 95% at six months with the first booster shot. Effectiveness against reinfection waned to 41% at 12 months and to 46% following the first booster shot at six months.

For breaking news and live news updates, like us on Facebook Get Latest Updates on Whatsapp or follow us on Twitter, Pin us and kooapp. Telegram. Read more on Latest Trending News, Entertainment News, Sports News, Govt. Schemes, on Follow Cemca news.

Leave a Comment